Allogeneic hematopoietic cell transplantation in patients with untreated acute myeloid leukemia: a KSGCT multicenter retrospective analysis

TY - JOUR

T1 - Allogeneic hematopoietic cell transplantation in patients with untreated acute myeloid leukemia

T2 - a KSGCT multicenter retrospective analysis

AU - on behalf of the Kanto Study Group for Cell Therapy (KSGCT)

AU - Tachibana, Takayoshi

AU - Ishizaki, Takuma

AU - Takahashi, Satoshi

AU - Najima, Yuho

AU - Kimura, Shun ichi

AU - Sakaida, Emiko

AU - Onizuka, Makoto

AU - Mori, Takehiko

AU - Fujisawa, Shin

AU - Fujiwara, Shin ichiro

AU - Saito, Takeshi

AU - Hagihara, Maki

AU - Aotsuka, Nobuyuki

AU - Gotoh, Moritaka

AU - Usuki, Kensuke

AU - Tsukada, Nobuhiro

AU - Kanda, Junya

AU - Kanamori, Heiwa

AU - Kanda, Yoshinobu

AU - Okamoto, Shinichiro

N1 - Funding Information: Conflict of interest KU reports grants and personal fees from MSD K.K., Sumitomo Dainippon Pharma, Pfizer Japan, and Celgene Corporation, grants from Astellas Pharma, Otsuka, Kyowa Kirin, Glax-oSmithKline K.K., Sanofi K.K., Shire Japan, SymBio Pharmaceuticals Limited., Daiichi Sankyo, Boehringer-Ingelheim Japan, and Janssen Pharmaceutical K.K, and personal fees from Novartis, Ono Pharmaceutical, Takeda Pharmaceuticals, Chugai Pharmaceutical, Nippon Shinyaku, and Mochida Pharmaceutical. Other authors declare that they have no conflict of interest.

PY - 2020/7/1

Y1 - 2020/7/1

UR - http://www.scopus.com/inward/record.url?scp=85073827765&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073827765&partnerID=8YFLogxK

U2 - 10.1038/s41409-019-0689-8

DO - 10.1038/s41409-019-0689-8

M3 - Letter

C2 - 31537900

AN - SCOPUS:85073827765

SN - 0268-3369

VL - 55

SP - 1497

EP - 1501

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

IS - 7

ER -